Sandalova, Sofya, Uğur Dal, and Arseniy Sandalov. “Early Post-Marketing Safety Signals of Anifrolumab in EudraVigilance: A Belimumab-Comparator Disproportionality Analysis”. International Journal of Medical Students (August 18, 2026). Accessed August 30, 2026. https://ijms.info/IJMS/article/view/4785.